196 related articles for article (PubMed ID: 24967971)
21. Interferon-γ treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjögren's Syndrome.
Meng Z; Klinngam W; Edman MC; Hamm-Alvarez SF
PLoS One; 2017; 12(9):e0184781. PubMed ID: 28902875
[TBL] [Abstract][Full Text] [Related]
22. A Multivalent ICAM-1 Binding Nanoparticle which Inhibits ICAM-1 and LFA-1 Interaction Represents a New Tool for the Investigation of Autoimmune-Mediated Dry Eye.
Hsueh PY; Ju Y; Vega A; Edman MC; MacKay JA; Hamm-Alvarez SF
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326657
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of Cathepsin S Reduces Lacrimal Gland Inflammation and Increases Tear Flow in a Mouse Model of Sjögren's Syndrome.
Klinngam W; Janga SR; Lee C; Ju Y; Yarber F; Shah M; Guo H; Wang D; MacKay JA; Edman MC; Hamm-Alvarez SF
Sci Rep; 2019 Jul; 9(1):9559. PubMed ID: 31267034
[TBL] [Abstract][Full Text] [Related]
24. Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome.
Fava RA; Kennedy SM; Wood SG; Bolstad AI; Bienkowska J; Papandile A; Kelly JA; Mavragani CP; Gatumu M; Skarstein K; Browning JL
Arthritis Res Ther; 2011; 13(6):R182. PubMed ID: 22044682
[TBL] [Abstract][Full Text] [Related]
25. The role of hypoxia-inducible factor-1α in radiation-induced autophagic cell death in breast cancer cells.
Zhong R; Xu H; Chen G; Zhao G; Gao Y; Liu X; Ma S; Dong L
Tumour Biol; 2015 Sep; 36(9):7077-83. PubMed ID: 25874499
[TBL] [Abstract][Full Text] [Related]
26. Improvement of lacrimal function by topical application of CyA in murine models of Sjögren's syndrome.
Tsubota K; Fujita H; Tadano K; Takeuchi T; Murakami T; Saito I; Hayashi Y
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):101-10. PubMed ID: 11133854
[TBL] [Abstract][Full Text] [Related]
27. Sjögren's syndrome-like ocular surface disease in thrombospondin-1 deficient mice.
Turpie B; Yoshimura T; Gulati A; Rios JD; Dartt DA; Masli S
Am J Pathol; 2009 Sep; 175(3):1136-47. PubMed ID: 19700744
[TBL] [Abstract][Full Text] [Related]
28. Augmented expression of CD44 splice variants in lymphoproliferative disorder of the lacrimal gland in Sjögren's syndrome.
Hiraoka M; Saito I; Tsubota K; Sugai S; Miyasaka N
Jpn J Ophthalmol; 1997; 41(5):312-8. PubMed ID: 9363560
[TBL] [Abstract][Full Text] [Related]
29. Lacrimal gland fluid secretion and lymphocytic infiltration in the NZB/W mouse model of Sjögren's syndrome.
Paranyuk Y; Claros N; Birzgalis A; Moore LC; Brink PR; Walcott B
Curr Eye Res; 2001 Sep; 23(3):199-205. PubMed ID: 11803482
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus and the lacrimal gland pathology of Sjögren's syndrome.
Pflugfelder SC; Crouse CA; Monroy D; Yen M; Rowe M; Atherton SS
Am J Pathol; 1993 Jul; 143(1):49-64. PubMed ID: 8391219
[TBL] [Abstract][Full Text] [Related]
31. Use of topical cyclosporin A in a primary Sjögren's syndrome mouse model.
Tsubota K; Saito I; Ishimaru N; Hayashi Y
Invest Ophthalmol Vis Sci; 1998 Aug; 39(9):1551-9. PubMed ID: 9699544
[TBL] [Abstract][Full Text] [Related]
32. Age-Related Conjunctival Disease in the C57BL/6.NOD-Aec1Aec2 Mouse Model of Sjögren Syndrome Develops Independent of Lacrimal Dysfunction.
You IC; Bian F; Volpe EA; de Paiva CS; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2224-33. PubMed ID: 25758816
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia inducible factor 1α contributes to regulation of autophagy in retinal detachment.
Shelby SJ; Angadi PS; Zheng QD; Yao J; Jia L; Zacks DN
Exp Eye Res; 2015 Aug; 137():84-93. PubMed ID: 26093278
[TBL] [Abstract][Full Text] [Related]
34. Tumor necrosis factor inhibitor gene expression suppresses lacrimal gland immunopathology in a rabbit model of autoimmune dacryoadenitis.
Zhu Z; Stevenson D; Schechter JE; Mircheff AK; Crow RW; Atkinson R; Ritter T; Bose S; Trousdale MD
Cornea; 2003 May; 22(4):343-51. PubMed ID: 12792478
[TBL] [Abstract][Full Text] [Related]
35. Inflammatory mediators in autoimmune lacrimal gland disease in MRL/Mpj mice.
Jabs DA; Gérard HC; Wei Y; Campbell AL; Hudson AP; Akpek EK; Lee B; Prendergast RA; Whittum-Hudson JA
Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2293-8. PubMed ID: 15223808
[TBL] [Abstract][Full Text] [Related]
36. [Apoptosis and related gene expression in lacrimal gland of cases with Sjögren's syndrome].
Wu J; Fei P; Gong Y; Zhao J; Dong J; Tang F
Zhonghua Yan Ke Za Zhi; 2000 Jul; 36(4):255-8, 14. PubMed ID: 11853607
[TBL] [Abstract][Full Text] [Related]
37. ENaC in the Rabbit Lacrimal Gland and its Changes During Sjögren Syndrome and Pregnancy.
Wang M; Huang J; Lu M; Zhang S; Ding C
Eye Contact Lens; 2015 Sep; 41(5):297-303. PubMed ID: 25828511
[TBL] [Abstract][Full Text] [Related]
38. Time course of cytokine upregulation in the lacrimal gland and presence of autoantibodies in a predisposed mouse model of Sjögren's Syndrome: the influence of sex hormones and genetic background.
Czerwinski S; Mostafa S; Rowan VS; Azzarolo AM
Exp Eye Res; 2014 Nov; 128():15-22. PubMed ID: 25218176
[TBL] [Abstract][Full Text] [Related]
39. IL-27 Regulated CD4
Qi J; Zhang Z; Tang X; Li W; Chen W; Yao G
Front Immunol; 2020; 11():1699. PubMed ID: 32849596
[TBL] [Abstract][Full Text] [Related]
40. Matriptase deletion initiates a Sjögren's syndrome-like disease in mice.
Yin H; Kosa P; Liu X; Swaim WD; Lai Z; Cabrera-Perez J; Di Pasquale G; Ambudkar IS; Bugge TH; Chiorini JA
PLoS One; 2014; 9(2):e82852. PubMed ID: 24551030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
